Skip to main content
TipRanks
Go Ultimate75% OFF

AIM Vaccine Co., Ltd. Class H (6660) Financial Statements

2 Followers

AIM Vaccine Co., Ltd. Class H Financial Overview

AIM Vaccine Co., Ltd. Class H's market cap is currently ¥1.83B. The company's EPS TTM is ¥-0.54; its P/E ratio is -2.38; AIM Vaccine Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.15B¥ 1.29B¥ 1.19B¥ 1.26B¥ 1.57B
Gross Profit¥ 760.20M¥ 953.51M¥ -611.21M¥ 1.03B¥ 1.29B
Operating Income¥ -207.87M¥ -210.91M¥ -3.51B¥ -384.33M¥ -648.73M
EBITDA¥ -49.54M¥ -57.89M¥ -2.05B¥ -242.03M¥ -451.71M
Net Income¥ -675.46M¥ -277.23M¥ -1.30B¥ -319.60M¥ -692.77M
Balance Sheet
Cash & Short-Term Investments¥ 384.72M¥ 594.87M¥ 736.41M¥ 818.91M¥ 746.74M
Total Assets¥ 6.55B¥ 7.31B¥ 7.26B¥ 8.88B¥ 8.07B
Total Debt¥ 1.76B¥ 1.84B¥ 1.80B¥ 1.40B¥ 650.43M
Net Debt¥ 1.39B¥ 1.35B¥ 1.21B¥ 763.49M¥ 3.69M
Total Liabilities¥ 3.61B¥ 3.70B¥ 3.37B¥ 3.01B¥ 2.37B
Stockholders' Equity¥ 2.76B¥ 3.37B¥ 3.64B¥ 4.96B¥ 4.89B
Cash Flow
Free Cash Flow¥ -171.39M¥ -139.09M¥ -467.14M¥ -966.96M¥ -1.05B
Operating Cash Flow¥ 67.47M¥ 99.19M¥ -165.50M¥ -110.32M¥ 93.40M
Investing Cash Flow¥ -107.73M¥ -162.34M¥ -271.96M¥ -858.15M¥ -1.34B
Financing Cash Flow¥ -111.65M¥ -26.22M¥ 362.07M¥ 980.37M¥ 788.02M

Currency in CNY

AIM Vaccine Co., Ltd. Class H Earnings and Revenue History

-1.5B01.5B3B-120 %-60 %0 %60 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

AIM Vaccine Co., Ltd. Class H Liabilities to Assets

04B8B12B24 %36 %48 %60 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

AIM Vaccine Co., Ltd. Class H Cash Flow

-1.5B-1B-500M0500M1B1.5B20182019202020212022202320242025OperatingInvestingFinancing

AIM Vaccine Co., Ltd. Class H Forecast EPS vs Actual EPS

-0.6-0.5-0.4-0.3-0.2-0.10Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss